total Eye Care PA

Memphis, Tennessee 38199

3 studies enrolling now · 77 studies all time

What they study most

Adenoviral Conjunctivitis, Allergic Conjunctivitis, Atopic Keratoconjunctivitis, Bacterial Conjunctivitis, Blepharitis, Dry Eye, Dry Eye Disease, Dry Eye Disease (DED), Dry Eye Syndrome, Dry Eye Syndromes, Elevated Intraocular Pressure, Eye Irritation

Studies at this site

• A Clinical Study Evaluating Licaminlimab for Dry Eye Disease — Recruiting now
• An Efficacy and Safety Study of DFL24498 in the Treatment of AKC — Recruiting now
• A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults — Recruiting now
• A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment — Completed
• Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension — Completed
• A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease — Completed
• Study of Rebamipide Eye Drops to Treat Dry Eye — Completed
• Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction — Completed
• Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia — Completed
• A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes — Completed
• A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease. — Completed
• An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations — Completed
• A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye — Completed
• Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension — Completed
• Next Generation Rocklatan — Completed
• Study Evaluating the Safety and Efficacy of AR-15512 — Completed
• Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease — Completed
• A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution — Completed
• A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease — Completed
• Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population — Completed
• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease — Completed
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease — Completed
• A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye — Completed
• A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease — Completed
• Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients — Completed
• A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease — Status unconfirmed
• Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease — Completed
• The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses — Completed
• Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia — Completed
• Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens — Completed
• Rocklatan® Evaluation — Completed
• Study of ST-100 as Treatment for Dry Eye Disease — Completed
• The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease — Completed
• Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED) — Status unconfirmed
• Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis — Completed
• A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease — Completed
• DE-117 Spectrum 5 Study — Completed
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study — Completed
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study — Completed
• Study of OT-101 in Treating Myopia — Running, not enrolling
• Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens — Completed
• A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle — Completed
• A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. — Completed
• A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease — Completed
• Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure — Status unconfirmed
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 — Completed
• Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 — Completed
• A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes — Completed
• Study of SkQ1 as Treatment for Dry-eye Syndrome — Completed
• A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia — Completed